Differential Association of Low-Fat and Whole-Fat Dairy Products with Blood Pressure and Incidence of Hypertension

Current Nutrition Reports

Volumn 1, Issue 4, 2012, Pages 197-204

  Toledo, Estefanía ^a   Alonso, Álvaro ^a,b   Martínez González, Miguel Á ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Blood pressure; Hypertension; Low fat dairy products; Whole fat dairy products

Indexed keywords

ALDOSTERONE; CALCIUM; COLECALCIFEROL; DIPEPTIDYL CARBOXYPEPTIDASE; MAGNESIUM; PALMITOLEIC ACID; PEPTIDE; PHOSPHORUS; POTASSIUM; SODIUM; VITAMIN D;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CALCIUM INTAKE; COHORT ANALYSIS; DAIRY PRODUCT; DISEASE ASSOCIATION; FAT CONTENT; FOLLOW UP; FOOD INTAKE; HUMAN; HYPERTENSION; INCIDENCE; META ANALYSIS (TOPIC); PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SODIUM BALANCE; SYSTEMATIC REVIEW (TOPIC);

EID: 85054627400     PISSN: None     EISSN: 21613311     Source Type: Journal    
DOI: 10.1007/s13668-012-0026-y     Document Type: Review

References (49)

1. Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524): 1747-57.
2. Toledo E, Carmona-Torre FA, Alonso A, et al. Hypothesis-oriented food patterns and incidence of hypertension: 6-year follow-up of the SUN (Seguimiento Universidad de Navarra) prospective cohort. Public Health Nutr. 2010; 13(3): 338-49.
3. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001; 344(1): 3-10.
4. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997; 336(16): 1117-24.
5. U. S. Department of Agriculture and U. S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010. Washington, DC; 2010.
6. •• McGrane MM, Essery E, Obbagy J, et al. Dairy consumption, blood pressure, and risk of hypertension: an evidence-based review of recent literature. Curr Cardiovasc Risk Rep. 2011; 5(4): 287-98. A recently published review that covers the topic on dairy consumptio, blood pressure and incident hypertension.
7. Svetkey LP, Simons-Morton D, Vollmer WM, et al. Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med. 1999; 159(3): 285-93.
8. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289(19): 2560-72.
9. Schulze MB, Hoffmann K, Kroke A, Boeing H. Risk of hypertension among women in the EPIC-Potsdam Study: comparison of relative risk estimates for exploratory and hypothesis-oriented dietary patterns. Am J Epidemiol. 2003; 158(4): 365-73.
10. Dauchet L, Kesse-Guyot E, Czernichow S, et al. Dietary patterns and blood pressure change over 5-y follow-up in the SU. VI. MAX cohort. Am J Clin Nutr. 2007; 85(6): 1650-6.
11. Ascherio A, Hennekens C, Willett WC, et al. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension. 1996; 27(5): 1065-72.
12. Alonso A, Beunza JJ, Delgado-Rodriguez M, et al. Low-fat dairy consumption and reduced risk of hypertension: the Seguimiento Universidad de Navarra (SUN) cohort. Am J Clin Nutr. 2005; 82(5): 972-9.
13. Wang L, Manson JE, Buring JE, et al. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008; 51(4): 1073-9.
14. Engberink MF, Hendriksen MA, Schouten EG, et al. Inverse association between dairy intake and hypertension: the Rotterdam Study. Am J Clin Nutr. 2009; 89(6): 1877-83.
15. Engberink MF, Geleijnse JM, de Jong N, et al. Dairy intake, blood pressure, and incident hypertension in a general Dutch population. J Nutr. 2009; 139(3): 582-7.
16. Toledo E, Delgado-Rodriguez M, Estruch R, et al. Low-fat dairy products and blood pressure: follow-up of 2290 older persons at high cardiovascular risk participating in the PREDIMED study. Br J Nutr. 2009; 101(1): 59-67.
17. Alonso A, Steffen LM, Folsom AR. Dairy intake and changes in blood pressure over 9 years: the ARIC study. Eur J Clin Nutr. 2009; 63(10): 1272-5.
18. •• Alonso A, Zozaya C, Vazquez Z, et al. The effect of low-fat versus whole-fat dairy product intake on blood pressure and weight in young normotensive adults. J Hum Nutr Diet. 2009; 22(4): 336-42. The only randomized controled trial assessing the differential effect of low-fat and whole-fat dairy products on blood pressure.
19. Sutoo D, Akiyama K. Regulation of blood pressure with calcium-dependent dopamine synthesizing system in the brain and its related phenomena. Brain Res Brain Res Rev. 1997; 25(1): 1-26.
20. Guyton AC, Hall JE. Textbook of medical physiology. 11th ed. Philadelphia: Elsevier Sauders; 2005.
21. Hilpert KF, West SG, Bagshaw DM, et al. Effects of dairy products on intracellular calcium and blood pressure in adults with essential hypertension. J Am Coll Nutr. 2009; 28(2): 142-9.
22. Dickinson HO, Nicolson DJ, Cook JV, et al., Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;(2): CD004639.
23. Margolis KL, Ray RM, van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension. 2008; 52(5): 847-55.
24. Jee SH, Miller 3rd ER, Guallar E, et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002; 15(8): 691-6.
25. Dickinson HO, Nicolson DJ, Campbell F, et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006;(3): CD004640.
26. Elliott P, Kesteloot H, Appel LJ, et al. Dietary phosphorus and blood pressure: international study of macro- and micro-nutrients and blood pressure. Hypertension. 2008; 51(3): 669-75.
27. Alonso A, Nettleton JA, Ix JH, et al. Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis. Hypertension. 2010; 55(3): 776-84.
28. Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem. 2003; 14(9): 492-506.
29. Tobian L, MacNeill D, Johnson MA, et al. Potassium protection against lesions of the renal tubules, arteries, and glomeruli and nephron loss in salt-loaded hypertensive Dahl S rats. Hypertension. 1984; 6(2 Pt 2): I170-6.
30. Fujita T, Sato Y. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension. 1992; 20(4): 466-72.
31. He FJ, Marciniak M, Carney C, et al. Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension. 2010; 55(3): 681-8.
32. Dickinson HO, Nicolson DJ, Campbell F, et al. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2006;(3): CD004641.
33. Vegarud GE, Langsrud T, Svenning C. Mineral-binding milk proteins and peptides; occurrence, biochemical and technological characteristics. Br J Nutr. 2000; 84 Suppl 1: S91-8.
34. FitzGerald RJ, Murray BA, Walsh DJ. Hypotensive peptides from milk proteins. J Nutr. 2004; 134(4): 980S-8.
35. Krum H, Viskoper RJ, Lacourciere Y, et al. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med. 1998; 338(12): 784-90.
36. Momose N, Fukuo K, Morimoto S, Ogihara T. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension. 1993; 21(6 Pt 2): 921-4.
37. Meisel H. Casokinins as inhibitors of angiotensin-I-converting enzyme. In: Sawatsky G, Renner B, editors. New perspectives in infant nutrition. New York: Thieme; 1993.
38. FitzGerald RJ, Meisel H. Lactokinins: whey protein-derived ACE inhibitory peptides. Nahrung. 1999; 43(3): 165-7.
39. FitzGerald RJ, Meisel H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br J Nutr. 2000; 84 Suppl 1: S33-7.
40. Xu JY, Qin LQ, Wang PY, et al. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition. 2008; 24(10): 933-40.
41. Pripp AH, Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr Res. 2008; 52.
42. Geleijnse JM, Engberink MF. Lactopeptides and human blood pressure. Curr Opin Lipidol. 2010; 21(1): 58-63.
43. • Cicero AF, Gerocarni B, Laghi L, Borghi C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J Hum Hypertens. 2011; 25(7): 425-36. A recently published metanalysis on the effects of lactotripeptides Valine-Proline-Pronline and Isoleucine-Proline-Proline on blood pressure levels.
44. Maes W, van Camp J, Vermeirssen V, et al. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept. 2004; 118(1-2): 105-9.
45. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr. 2007; 137(3 Suppl 2): 825S-9.
46. Moers A, Schrezenmeir J. Palmitic acid but not stearic acid inhibits NO-production in endothelial cells. Exp Clin Endocrinol Diabetes. 1997; 105 Suppl 2: 78-80.
47. Sarabi M, Vessby B, Millgard J, Lind L. Endothelium-dependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects. Atherosclerosis. 2001; 156(2): 349-55.
48. Esmaillzadeh A, Azadbakht L. Dairy consumption and circulating levels of inflammatory markers among Iranian women. Public Health Nutr. 2010; 13(9): 1395-402.
49. Zheng ZJ, Folsom AR, Ma J, et al. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1999; 150(5): 492-500.